Ultrasound Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

According to a new market report published by Transparency Market Research "Ultrasound Devices Market (By Product Type - Cart/Trolley Based Ultrasound Devices and Compact Ultrasound Devices, By Technology - 2-D, 3-D & 4-D, Doppler, HIFU and Lithotripsy and By Application - Obstetrics and Gynecology, Cardiovascular, Abdominal and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global ultrasound devices market was valued at USD 5.40 billion in 2012 and is expected to grow at a CAGR of 6.4% during the forecast period 2013 to 2019 to reach a market value of USD 8.71 billion by 2019.

Browse the full Ultrasound Devices Market report at http://www.transparencymarketresearch.com/ultrasound-devices-market.html

Ultrasound devices enable physicians in diagnosing diseases for their further appropriate treatments. In addition, these devices also help surgeons by guiding movement of surgical instrument in patient's body while performing surgeries. These devices are utilized extensively for abdominal imaging and examining various abdominal disorders such as stomach cancer. The global market for ultrasound devices has been estimated to grow at a CAGR of 6.4% (by value) and 8.8% (by volume) during the forecast period 2013 to 2019. The growth of ultrasound devices market is expected to increase with rising incidences of various diseases such as cardiovascular diseases and cancer. Technological advancements in ultrasound devices is further expected to propel the uptake of ultrasound devices market since new technologies that are revolutionizing the ultrasound industry are efficient to diagnose complex diseases with high precision and less time consumption. For instance, unlike CT scanners, 3-D & 4-D ultrasound imaging technology is efficient in producing real-time images of anatomical structure of organs. Likewise, increasing government initiatives will also accentuate the growth of this market during the forecast period.

Get Free Sample Report at http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2483

Ultrasound devices market has been segmented based on product type as cart/trolley based ultrasound devices and compact ultrasound devices. Owing to rising number of surgeries, compact ultrasound devices market is projected to grow at the highest CAGR of 11.5% by value during the forecast period 2013 to 2019. Unlike cart/trolley based ultrasound devices, compact ultrasound devices are small in size that enable their easy movement while performing surgeries, hence are preferred in operating rooms. In addition, increasing government funding for compact ultrasound devices will further expedite the growth of this market. Various technologies have been invented for ultrasound devices to increase their efficiency. In 2012, 2-D ultrasound imaging technology market accounted for the largest share by value and is estimated to grow at steady CAGR during the study period. The large market size is attributed to its presence in the market since a long time that has helped gain popularity among radiologists.

Browse more Medical Devices Related Report at http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html

Based on application, ultrasound devices market has been segmented as obstetrics and gynecology, cardiovascular, abdominal and others (lungs, soft tissue and interventional radiology). Among all these, cardiovascular ultrasound imaging market is expected to grow at the highest CAGR during the forecast period. This growth is due to the fact that ultrasound devices have proven their efficiency in diagnosing various cardiovascular diseases precisely with the advent of 3-D & 4-D imaging and Doppler ultrasound imaging technique. Hence, with rising incidences of various cardiovascular diseases, cardiovascular ultrasound imaging market is expected to grow in the coming years.

Download PDF at Ultrasound Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Africa Printer Market - Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

According to a new market report published by Transparency Market Research "Printer Market - Africa Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the printer market in Africa was worth USD 2,300.0 million in 2012 and is expected to reach USD 4,181.3 million by 2019, growing at a CAGR of 8.8% from 2013 to 2019. Within Africa, South Africa was the largest market for printers in 2012. The growth is primarily driven by increase in usage of multifunction printers (MFP) in government and corporate segments.

Browse the full Africa Printer Market report at http://www.transparencymarketresearch.com/printer-market.html

Growth of MFP market and increase in demand for managed print services (MPS) and solutions are the key factors driving the growth of African printers market. Emergence of advanced technology printers such as high speed laser printers and color laser printers is driving the need to replace older printing infrastructure, thus fueling market growth. However, shift in workflow from hard copy to electronic format is one of the factors inhibiting market growth.

Get Free Sample Report at http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2486

Among all product types, laser printer was the largest segment in 2012 and accounted for 76.8% share of the total market. The segment is also expected to witness highest growth during the forecast period. Inkjet printers are finding significant demand in large format printing owing to benefits such as environment friendliness and better color effect. The growth of large format printing is expected to aid the growth of inkjet printers market.

Browse more Semiconductor and Electronics related reports at http://www.transparencymarketresearch.com/semiconductor-market-reports-5.html

Geographically, South Africa was the largest printer market accounting for 20.8% share in 2012 and is expected to observe the highest growth throughout the forecast period. This growth is attributed mainly to increase in demand for multifunction printers (MFP) in corporate and government sector.

The report studies the printer market in Africa, and provides estimates in terms of revenue (USD million) from 2013 to 2019.

Browse Blog https://tmrresearch.wordpress.com/

Pharmacovigilance Market and Service Providers - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

Pharmacovigilance Market

Transparency Market Research Report published "Pharmacovigilance Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" to its database. A rising tide of regulatory expectations, tougher inspection regime and instant need of patient reporting has provided the much needed impetus for the growth of the pharmacovigilance market. An upsurge in number of acute and chronic diseases has consequently led to a rise in number of drug consumption, which has also elicited a growth in the number of adverse drug events and drug toxicity cases.

Browse the report with Full TOC at http://www.transparencymarketresearch.com/pharmacovigilance-market.html

Moreover, several high-profile safety issues, regulatory warnings, large volume of events to be reviewed along with negative media coverage have compelled the pharmaceutical players to take support of various outsourcing services. There are two major outsourcing services opted by these pharmaceutical players i.e. traditional CROs and BPOs. These outsourcing services not only provide cost savings but also helps in bringing process efficiency. Pharmaceutical companies are now forming long term partnership with the CROs and BPOs to share the costs involved in PV process right from drug discovery to post marketing approvals. In addition, PV requires skilled resources with excellent language skills and strong knowledge pertaining to case reporting.

Get Free Sample Report at http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1729

The research report on pharmacovigilance provides detailed analysis of the global market and helps in understanding the driving forces responsible for the growth of this market. The report discusses the market of pharmacovigilance market on the bases of clinical trials phases i.e. Phase I to III and post marketing surveillance (PMS). We have also mapped the trend for preference of the pharmaceutical players for in-house and outsourcing in our chapter by type of service.

The global pharmacovigilance market has been segmented based on all the above mentioned parameters and market size estimates and forecasts for the period of 2011 to 2019 have been provided for each of the segments, in term of USD million, considering 2012 as the base year for calculations and 2011 representing as the historical year. The CAGR (%) of each market segment for the forecast period 2013 to 2019 has also been provided along with market size estimations.

The report exclusively studies the aforementioned segments with respect to geography. Under geographic section we have covered four regions, namely, North America, Europe, Asia-Pacific and Rest of the World (ROW).

Bowse more healthcare IT related report at http://www.transparencymarketresearch.com/healthcareit-market-reports-19.html

The market overview section gives a detailed qualitative analysis of the factors responsible for driving and restraining the growth of the global pharmacovigilance market. The section also covers opportunities and market attractiveness analysis of the geographical regions.

The report concludes with the competitive landscape and company profiles of major market players. These market players have been profiled on the basis of various attributes such as company overview, financial overview, business strategies, product portfolio and recent developments. Some of the major players profiled in this report include PRA International Inc., Covance Inc., Synowledge LLC, OptumInsight Inc., iMedGlobal, TCS, iGATE Corporation, Cognizant Technology Solutions, Quintiles and others.

Download PDF at Pharmacovigilance Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Construction Paints and Coatings Market in 2013-2019: Transparency Market Research

The demand for construction paints and coatings is mainly prompted by growing infrastructure activities globally and the growing demand for water borne paints and coatings. Asia Pacific dominates the global market for construction paints and coatings. This report by Transparency Market Research analyses, estimates and forecasts the construction paints and coatings demand on a global and regional level for a six year period from 2013 to 2019, both in terms of volume and revenue. The study also provides information on restraints, drivers and opportunities along with the impact on the overall market for the forecast period. The report segments the market based on application and region and offers estimates and forecast of the construction paints and coatings market for each segment.

Browse the report with Full TOC at http://www.transparencymarketresearch.com/construction-paints-coatings-market.html

The study analyses the product value chain beginning with feed stock material up to end-use. In addition, it also evaluates the market based on Porter’s five forces model that analyses the degree of competition in the market by considering factors such as the bargaining power of buyers and suppliers, threat from substitute products and new entrants. The report includes a detailed competitive landscape of the construction paints and coatings market, including company market share analysis and the profile of key market participants.

The report provides a decisive view on the construction paints and coatings market by segmenting the market based on product types and applications. Product segments analyzed in this report include High solids/radiation cured, Powder coatings, water borne coatings, solvent borne coatings and others (Specialty coatings). Based on applications, construction paints and coatings are segmented into architectural paints and others (Special purpose coatings, etc.). All application segments have been analyzed based on present and future trends and the market is estimated from 2013 to 2019.

Get Free Sample Report at http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1840

The construction paints and coatings market is segmented regionally in North America, Europe, Asia Pacific, Latin America and Rest of the World. The demand of each application type of construction paints and coatings in terms of both revenue and consumption for each of these regions is forecast in this report for the period 2013 to 2019.

Browse more Chemical and Materials related reports at http://www.transparencymarketresearch.com/chemical-market-reports-2.html

Some of the leading manufacturers profiled in this report include The Sherwin-Williams Company, PPG Industries, The Valspar Corporation, Dow Corning and Asian Paints among others. These companies are profiled in detail covering features such as company overview, financial overview, business strategies, SWOT analysis, and recent developments.

Download PDF at Construction Paints and Coatings Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Prenatal and Newborn Genetic Testing Market Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

According to a new market report published by Transparency Market Research "Prenatal and Newborn Genetic Testing Market (PCR, FISH, aCGH, NIPT and MSS): Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" the global prenatal and newborn genetic testing market was valued USD 1.12 billion in 2012 and expected to grow at a CAGR of 26.9% from 2013 to 2019, to reach an estimated value of USD 8.37 billion in 2019.

Browse Global Prenatal and Newborn Genetic Testing Market Report with Full TOC at http://www.transparencymarketresearch.com/prenatal-new-born-genetic-testing.html

Prenatal and newborn genetic testing is referred to the utilization of screening/diagnostic procedures for a fetus or a new born baby to detect chromosomal abnormalities such as Down syndrome, Patau syndrome and Edward syndrome. These testing procedures enable detection of certain genetic abnormalities in as early as 8 to 10 weeks of gestation and also help to determine the sex of the fetus. According to Northwestern Medical Faculty Foundation, Down syndrome, open neural tube defects and trisomy 18 are the birth defects that 85% of women are advised to be screened or tested during pregnancy. Whereas, there are some tests which provides information about trisomy 13 and other chromosome abnormalities. Prenatal and newborn genetic tests are of two types, diagnostic and screening tests. Diagnostic tests helps to confirm the presence of certain genetic conditions in a fetus or a new born baby, while screening tests detects the chance of development of certain genetic abnormalities in a fetus or new born baby.

Get Free Sample Report at:http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1744

The prenatal and newborn genetic testing market is driven by increasing maternal age and late pregnancies, technological advancements and growing awareness about genetic disorders in the fetus. It was also observed that the prenatal and newborn genetic testing market is still at a nascent stage and have many opportunities such as capitalizing on potential markets in the emerging Asian, African and Latin American countries. In diagnostic techniques market, polymerase chain reaction (PCR) segment accounted for the largest share, as compared to FISH and aCGH. The PCR market is mainly driven by rising incidences of genetic diseases and forensics coupled with high process efficiency, better precision and reliability of the technique, and amplification. Non-invasive prenatal testing (NIPT) is the largest market segment in screening method and is expected to grow at highest CAGR of 37.6% from 2013 to 2019.

Browse all Pharmaceutical Market Research Reports @ http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

The North American region accounted for the largest share of the total prenatal and newborn genetic testing market. One of the key factors driving the growth of North America market is the non-invasive nature of the test that completely eliminates the risk of miscarriage associated with invasive tests such as amniocentesis and CVS (Chorionic Villus Sampling).

The diagnostic testing techniques market consists of key players such as Bio-Rad Laboratories, Agilent Technologies, Perkin Elmer and Ariosa Diagnostics. Agilent Technologies and Bio-Rad Laboratories are the leading players in diagnostic testing techniques market because of their dominance in reagents and instruments market. Major players of the screening methods market are Sequenom, Inc., Illumina, Inc. and Natera, Inc. Overall Sequenom, Inc. and Verinata Health are the major market players of the global prenatal and newborn genetic testing market because of their initial product launches in this market.

Download PDF Prenatal and New-born Genetic Testing Market in 2013 – 2019 :Transparency Market Research

Negative Pressure Wound Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

According to a new market report published by Transparency Market Research "Negative Pressure Wound Therapy Market (Conventional and Single Use NPWT Systems) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global negative pressure wound therapy devices market was valued at USD 2.1 billion in 2012 and is expected to grow at a CAGR of 10.2% from 2013 to 2019, to reach an estimated value of USD 4.2 billion in 2019.

Rise in the number of chronic diseases such as diabetes, cardiovascular diseases, peripheral vascular diseases has triggered the growth of negative pressure wound care therapy (NPWT) market.

Browse Negative Pressure Wound Therapy (NPWT) Market Report With Full TOC http://www.transparencymarketresearch.com/negative-pressure-wound-therapy.html

Moreover, increasing incidence of cancer and neurological diseases has led to long-term bed occupancy of the affected patients thus increasing the incidence rate of decubitus ulcers. The ever increasing geriatric population globally has caused a significant financial burden on the healthcare authorities. To manage this situation patients are preferring usage of portable and easy to use NPWT devices that may be used as a home healthcare devices. This has helped in minimizing the overall cost of the hospital stay. In addition, companies in this industry are trying to stay abreast with technological innovations such as launch of single use NPWT devices that may reduce the chances of contamination. These companies are also increasingly focusing on R&D to introduce patient friendly NPWT devices at minimal cost.

Get Free Sample Report at http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1718

According to the American Diabetes Association nearly 26 million children and adults are currently suffering from diabetes. The association has also stated that 15% of people with diabetes experience a foot ulcer at some point in their lifetime. The diabetic foot ulcer causes various complications such as ulceration, infection and gangrene thus leading to complex and costly sequel of diabetes. The role of negative pressure wound care therapy has been considered to be a novel therapy for treatment of diabetic foot ulcers. This significant population of diabetic foot ulcers has boosted the demand for NPWT devices market.

The NPWT devices market has been primarily segmented into conventional NPWT devices and single use NPWT devices. The conventional NPWT devices market further comprises pumps, canisters, tubes and dressing kits. The NPWT pumps market of the conventional NPWT devices accounted for the largest market. Among these the dressing kits market is expected to foresee the highest growth rate during the forecast period. However, the single use NPWT devices are anticipated to grow at the highest growth rate of over 12% from 2013 to 2019.

Browse Medical Devices Market Reports @ http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html

Geographically North America accounted for the largest market in the year 2012 followed by Europe. However, Asia Pacific is estimated to have the fastest growth rate owing to rise in chronic diseases coupled with rise in disposable income and growing awareness.

The major players of this market include Kinetic Concepts Inc., Smith & Nephew, Talley Group Ltd, Convatec, Molnlycke Health Care AB, ArjoHuntleigh Healthcare Ltd, Medela, Inc., Prospera and Genadyne.

Download PDF at Negative Pressure Wound Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

Meningococcal Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

According to a new report published by Transparency Market Research "Meningococcal Vaccines Market (Polysaccharide, Conjugate, and Combination Vaccines, along with Pipeline Analysis) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the market for meningococcal vaccines was valued at USD 1.5 billion in 2012 and is expected to reach a value of USD 3.7 billion in 2019, growing at a CAGR of 14.9% from 2013 to 2019.

Browse Meningococcal Vaccines Market Report With Full TOC at http://www.transparencymarketresearch.com/meningococcal-vaccines-market.html

Meningococcal disease is caused by the bacterium Neisseria meningitidis and occurs sporadically throughout the world with seasonal variations. It accounts for a proportion of endemic bacterial meningitis, which can progress very rapidly leading to death within 24 hours from the onset of symptoms. The disease is often misinterpreted as common flu in most of the cases. Five out of the several serogroups are known to cause meningococcal disease. These serogroups responsible for the disease comprises serogroups A, B, C, Y and W-135. The causative agent N. meningitidis is commonly found in the nasopharynx of humans and gets transmitted through droplet inhalation by means of close contact such as exposure to smokers, crowded living conditions such as dormitories, certain inherited disorders of the immune system, functional/anatomical asplenia or though intimate oral contact among others. According to European Federation of Pharmaceutical Industries and Association every year meningitis affects almost 5 lakh people globally, primarily affecting toddlers, infants and young adults, due to weaker immune system.

Get Free Sample Report at http://www.transparencymarketresearch.com/meningococcal-vaccines-market.html

The global market for meningococcal vaccines is segmented broadly into vaccine types namely, polysaccharide, conjugate and combination vaccines. The report also provides analysis for vaccines under development that are expected to be commercialized during the forecast period 2013 to 2019. The vaccine types are further segmented by different brands available in the market. The conjugate vaccines segment is likely to lead the overall meningococcal vaccines market in terms of revenue, which is estimated to reach approximately USD 2.5 billion by 2019 at a CAGR of 12.9%. Amongst the pipeline vaccines, Novartis's Bexsero is expected to grow at the fastest rate of 24.7% during the forecast period 2013 to 2019. According to Department of Health, U.K., Bexsero is the first serogroup B vaccine to be incorporated into the national immunization program and is expected to be available in the market for sales by the second quarter of 2014. The MnB rLP2086 vaccine from Pfizer is currently in phase III clinical trials and has been granted with Breakthrough Therapy status by U.S. FDA in 2014.

Geographically, North America lead the global meningococcal vaccines market in 2012 due to government interventions, wider immunization programs, and favorable research and development initiative by manufacturers. According to National Meningitis Association of the U.S., about 20 percent of all meningococcal disease cases occur in teens and young adults aged 14 years to 24 years. As per the Centers for Disease Control and Prevention (CDC) 1,000 to 2,600 people contract meningitis annually in the U.S. Meningococcal vaccines licensed in the U.S. are only against A, C, Y and W-135 serogroups and not against serogroup B. The use of Bexsero as an Investigational New Drug (IND) in combating the disease during the outbreaks in Princeton University and University of California, Santa Barbara in 2013, is likely to clear the way for Bexsero's approval in the U.S. market sooner than expected. This region is followed by Rest of the World comprising the Latin American countries, the Middle East and African countries. This has been attributed to the high incidence rate of meningococcal diseases in this region. Europe accounts for the lowest CAGR due to rise free sales of the vaccines especially meningococcal C vaccines.

Browse Pharmaceutical Market Reports @ http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

By 2019, Asia-Pacific is estimated to be the fastest growing regional market with a CAGR of around 17.1%. Major drivers for this market include low cost of manufacturing and transfer of novel technologies with respect to vaccine manufacturing, from developed parts of the world to the emerging economies. Advancements in manufacturing technology have been helping companies in manufacturing novel products that are not only affordable in developing and underprivileged nations, but are also comparable in terms of quality to their high-end alternatives.

The global market for meningococcal vaccines is largely driven by increasing government intervention in reforming the healthcare infrastructure and incorporation of legislations specific to meningococcal vaccination. The public-private partnerships for conducting research and development, and manufacturing of quality vaccines at an affordable price are also contributing positively in driving market growth. Awareness campaigning from government and non-profit organizations and obligatory immunization for individuals heading to Mecca (for Hajj pilgrimage) and the South African meningitis belt will also contribute to growth of this market. High cost of few but vital vaccines, such as Bexsero, and need for efficient cold chain logistics to maintain safety and efficacy of the vaccine are expected to be some of the major factors posing a challenge to the adequate uptake of these vaccines.

The key players dominating in the global meningococcal vaccines include Sanofi Pasteur (the vaccine division of Sanofi SA), Novartis International AG and GSK plc. These players account for more than 80% of the meningococcal vaccines market. Players such as Serum Institute of India Ltd., JN International Medical Corporation, Biomed Pvt. Ltd., Nuron Biotech and Baxter account for the remaining market share.

Download PDF at Meningococcal Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019